Growth hormone stimulating drug could help prevent liver disease
23 Oct 2019
According to a study published in The Lancet HIV, an injectable synthetic form of growth-hormone-stimulating hormone, tesamorelin, reduces liver fat and risk of liver fibrosis in patients with HIV.
